₹6.50

Listing Status: Active
Provider of an online pharmacy and healthcare platforms. It offers a wide range of pharmaceutical products, healthcare and wellness items,...
Total Rounds: 11 Pharmeasy
| S.No. | Date | Round Name | Amount | TTM Revenue | Investors & Facilitators |
|---|---|---|---|---|---|
| 1. | Sep 16, 2025 | Conventional Debt | $193M | $7.1M | Inst: 360 One, Bennett, Coleman |
| 2. | May 10, 2022 | Series F | - | $42.0M | Inst: GSV |
| 3. | Feb 21, 2022 | Series F | - | $41.7M | Inst: GSV |
| 4. | Jun 28, 2021 | Series F | $300M | $23.0M | Inst: Temasek, TPG, Prosus, Think Investments, Kotak Investment Advisors, B Capital |
| 5. | Feb 24, 2021 | Series D | $66.4M | $16.8M | Inst: Temasek, Caisse de depot et placement du Quebec, Timesgroup, TPG, Lightrock |
| 6. | Nov 26, 2019 | Series D | $220M | - | Inst: Temasek, Bessemer Venture Partners, Orios Venture Partners, Eight Roads Ventures, F-Prime Capital, Fundamentum, Avendus, Caisse de depot et placement du Quebec, KB Global Holdings, KB Investment, Think Investments, LGT Group Angel: Nandan, Sanjeev, Harsh, Hardik |
| 7. | Sep 26, 2018 | Series C | $50M | - | Inst: Fundamentum, Eight Roads Ventures, F-Prime Capital, Bessemer Venture Partners, Ascent Health & Wellness Solutions, Think Investments Angel: Bina, Anuj, Manju, Ramakant Facil: Avendus |
| 8. | Sep 11, 2018 | Venture Debt | $5.5M | - | Inst: Innoven Capital |
| 9. | Feb 28, 2018 | Series C | $30M | - | Inst: Bessemer Venture Partners, Orios Venture Partners, Trifecta Capital, Ascent Health & Wellness Solutions, MEMG Family Office, JM Financial |
| 10. | Mar 25, 2017 | Series B | $17M | - | Inst: Bessemer Venture Partners, Orios Venture Partners, Trifecta Capital, Ascent Health & Wellness Solutions Angel: Shivanand, Laxmi, Kedar |
| 11. | 2015 | Series A | $5M | - | Inst: Bessemer Venture Partners, Orios Venture Partners, Aarin Capital, Astarc Ventures, Ascent Health & Wellness Solutions, MediBuddy |
| Detailed Income Statement | FY 24-25 (in Cr) |
|---|---|
| 75.5 | |
| 75.2 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 0.3 |
| Total profit before extraordinary items and tax | 0.3 |
| Total profit before tax | 0.3 |
| 0 | |
| Total profit (loss) for period from continuing operations | 0.3 |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) for period before minority interest | 0.3 |
| Profit (loss) of minority interest | 0 |
| Total profit (loss) for period | 0.3 |
| Basic earning per equity share | 0.0 |
| Diluted earnings per equity share | 0.0 |
| Detailed Balance Sheet | FY 24-25 (in Cr) |
|---|---|
| 35.7 | |
| 35.7 |
| Detailed Cash Flow Statement | FY 24-25 (in Cr) |
|---|---|
| Cash flow from operating activities | 1.4 |
| Net cash from / (used in) operating activities | 1.4 |
| Cash flow from investing activities | 1.1 |
| Net cash from / (used in) investing activities | 1.1 |
| Cash flow from financing activities | (4.1) |
| Net cash from / (used) in financing activities | (4.1) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (1.5) |
| Net increase / (decrease) in cash and cash equivalents | (1.5) |
| Cash and cash equivalents at the beginning of the year | 8.2 |
| Cash and cash equivalents at the end of the year | 6.7 |
| Detailed Income Statement | FY 23-24 (in Cr) |
|---|---|
| 103.8 | |
| 104.0 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (0.2) |
| Total profit before extraordinary items and tax | (0.2) |
| Total profit before tax | (0.2) |
| 0 | |
| Total profit (loss) for period from continuing operations | (0.2) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) for period before minority interest | (0.2) |
| Profit (loss) of minority interest | 0 |
| Total profit (loss) for period | (0.2) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 23-24 (in Cr) |
|---|---|
| 33.2 | |
| 33.2 |
| Detailed Cash Flow Statement | FY 23-24 (in Cr) |
|---|---|
| Cash flow from operating activities | 6.4 |
| Net cash from / (used in) operating activities | 6.4 |
| Cash flow from investing activities | (0.1) |
| Net cash from / (used in) investing activities | (0.1) |
| Cash flow from financing activities | (5.4) |
| Net cash from / (used) in financing activities | (5.4) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 0.9 |
| Net increase / (decrease) in cash and cash equivalents | 0.9 |
| Cash and cash equivalents at the beginning of the year | 7.3 |
| Cash and cash equivalents at the end of the year | 8.2 |
| Detailed Income Statement | FY 22-23 (in Cr) |
|---|---|
| 258.3 | |
| 259.0 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (0.8) |
| Total profit before extraordinary items and tax | (0.8) |
| Total profit before tax | (0.8) |
| 0 | |
| Total profit (loss) for period from continuing operations | (0.8) |
| Profit (loss) from discontinuing operations before tax | 0 |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) for period before minority interest | (0.8) |
| Profit (loss) of minority interest | 0 |
| Total profit (loss) for period | (0.8) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 22-23 (in Cr) |
|---|---|
| 51.9 | |
| 51.9 |
| Detailed Cash Flow Statement | FY 22-23 (in Cr) |
|---|---|
| Cash flow from operating activities | 9.5 |
| Net cash from / (used in) operating activities | 9.5 |
| Cash flow from investing activities | (0.7) |
| Net cash from / (used in) investing activities | (0.7) |
| Cash flow from financing activities | (11.1) |
| Net cash from / (used) in financing activities | (11.1) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | (2.3) |
| Net increase / (decrease) in cash and cash equivalents | (2.3) |
| Cash and cash equivalents at the beginning of the year | 9.5 |
| Cash and cash equivalents at the end of the year | 7.3 |
| Detailed Income Statement | FY 21-22 (in Cr) |
|---|---|
| 327.9 | |
| 319.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 8.6 |
| Total profit before extraordinary items and tax | 8.6 |
| Total profit before tax | 8.6 |
| 0.3 | |
| Total profit (loss) for period from continuing operations | 8.3 |
| Profit (loss) from discontinuing operations before tax | (13.7) |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | (13.7) |
| Total profit (loss) for period before minority interest | (5.4) |
| Profit (loss) of minority interest | 0 |
| Total profit (loss) for period | (5.4) |
| Basic earning per equity share | (0.0) |
| Diluted earnings per equity share | (0.0) |
| Detailed Balance Sheet | FY 21-22 (in Cr) |
|---|---|
| 88.2 | |
| 88.2 |
| Detailed Cash Flow Statement | FY 21-22 (in Cr) |
|---|---|
| Cash flow from operating activities | 21.6 |
| Net cash from / (used in) operating activities | 21.6 |
| Cash flow from investing activities | 0.3 |
| Net cash from / (used in) investing activities | 0.3 |
| Cash flow from financing activities | 29.0 |
| Net cash from / (used) in financing activities | 29.0 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 50.9 |
| Net increase / (decrease) in cash and cash equivalents | 50.9 |
| Cash and cash equivalents at the beginning of the year | 1.9 |
| Cash and cash equivalents at the end of the year | 9.5 |
| Detailed Income Statement | FY 20-21 (in Cr) |
|---|---|
| 119.0 | |
| 98.3 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | 20.7 |
| Total profit before extraordinary items and tax | 20.7 |
| Total profit before tax | 20.7 |
| (0.1) | |
| Total profit (loss) for period from continuing operations | 20.8 |
| Profit (loss) from discontinuing operations before tax | (19.8) |
| Tax expense of discontinuing operations | 0 |
| Total profit (loss) from discontinuing operation after tax | (19.8) |
| Total profit (loss) for period before minority interest | 1.0 |
| Profit (loss) of minority interest | 0 |
| Total profit (loss) for period | 1.0 |
| Basic earning per equity share | 0.0 |
| Diluted earnings per equity share | 0.0 |
| Detailed Balance Sheet | FY 20-21 (in Cr) |
|---|---|
| 38.8 | |
| 38.8 |
| Detailed Cash Flow Statement | FY 20-21 (in Cr) |
|---|---|
| Cash flow from operating activities | 0.5 |
| Net cash from / (used in) operating activities | 0.5 |
| Cash flow from investing activities | (0.1) |
| Net cash from / (used in) investing activities | (0.1) |
| Cash flow from financing activities | 0 |
| Net cash from / (used) in financing activities | 0 |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 0.5 |
| Net increase / (decrease) in cash and cash equivalents | 0.5 |
| Cash and cash equivalents at the beginning of the year | 1.4 |
| Cash and cash equivalents at the end of the year | 1.9 |
| Detailed Income Statement | FY 19-20 (in Cr) |
|---|---|
| 181.7 | |
| 194.1 | |
| Total profit before prior period items, exceptional items, extraordinary items and tax | (12.5) |
| Total profit before extraordinary items and tax | (12.5) |
| Total profit before tax | (12.5) |
| (0.1) | |
| Total profit (loss) for period from continuing operations | (12.3) |
| Total profit (loss) for period before minority interest | (12.3) |
| Total profit (loss) for period | (12.3) |
| Basic earning per equity share | 0 |
| Diluted earnings per equity share | 0 |
| Detailed Balance Sheet | FY 19-20 (in Cr) |
|---|---|
| 33.1 | |
| 33.1 |
| Detailed Cash Flow Statement | FY 19-20 (in Cr) |
|---|---|
| Cash flow from operating activities | 11.7 |
| Net cash from / (used in) operating activities | 11.7 |
| Cash flow from investing activities | (1.6) |
| Net cash from / (used in) investing activities | (1.6) |
| Cash flow from financing activities | (4.1) |
| Net cash from / (used) in financing activities | (4.1) |
| Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes | 5.9 |
| Net increase / (decrease) in cash and cash equivalents | 5.9 |
| Cash and cash equivalents at the beginning of the year | 0 |
| Cash and cash equivalents at the end of the year | 5.9 |